Safety and efficacy of single intravitreal injection of ranibizumab in macular edema secondary to recent nonischemic retinal vein occlusion

Objectives This study was designed to evaluate the safety and efficacy of a single large dose (0.7 mg) of ranibizumab for treatment of macular edema secondary to nonischemic central retinal vein occlusion (CRVO) or branch retinal vein occlusion (BRVO). Setting and design A prospective interventional...

Full description

Bibliographic Details
Main Author: Walid Ibrahim
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2017-01-01
Series:Delta Journal of Ophthalmology
Subjects:
Online Access:http://www.djo.eg.net/article.asp?issn=1110-9173;year=2017;volume=18;issue=1;spage=44;epage=47;aulast=Ibrahim